Abstract:The use of high-field magnets for magnetic resonance imaging (MRI) is expected to experience the fastest growth rate during the present decade. Although several CAs for MRI scanners using high magnetic fields have been reported, they are mostly based on fluoride matrices, which are known for their low chemical stability in aqueous suspensions. Chemically stable MRI CAs for high-field magnets are therefore needed to enable the advances in MRI technique. Herein, we synthesized uniform DyPO4 nanoparticles (NPs) with tuneable sizes between 23 and 57 nm using homogeneous precipitation in butanol. The NPs were successfully functionalized with polyacrylic acid (PAA) and showed good colloidal stability in aqueous suspensions. Chemical stability was also assessed in PBS, showing negligible solubility. The effect of particle size on the transversal relaxivity value (r2) was further explored at 9.4 T, finding a clear increase in r2 with particle size. The r2 value found for the largest NPs was 516 mM-1 s-1, which is, to the best of our knowledge, the highest r2 value ever reported at 9.4 T for any Dy-based nanometric particles in the literature. Finally, the latter NPs were submitted to biosafety studies after polyethylene glycol (PEG) functionalization. Cell morphology, induction of necrotic/late apoptotic cells, and mitochondrial activity were thoroughly analyzed. The results clearly indicated negligible toxicity effects under the assayed conditions. Short- and long-term in vivo pharmacokinetics of the intravenously injected NPs were assessed by dynamic T2-weighted MRI and quantitative T2 mapping, revealing faster liver than spleen uptake, while no accumulation was observed in the kidneys. Finally, no histopathological changes were observed in any of the studied organs, including the liver, kidney, spleen, and lung, which provide further evidence of the biocompatibility of DyPO4 NPs and, therefore, their suitability as bioimaging probes.

Synthesis of iron oxide-gadolinium oxide nanocomposite produced by pulse laser ablation in carboxy methylcellulose as a contrast agent of magnetic resonance imaging

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Synthesis of Gadolinium Nanoparticles as a CT-Scan Contrast Agent with Pulse Laser Ablation Method

Synthesis, Characterization, and In Vitro Study of Dextrin-Coated Bismuth-Doped Manganese Ferrite Nanoparticles (Bio.3Mno.55Fe2O4) as an MRI Contrast Agent

2, 3-Dimercaptosuccinic Acid-Modified Iron Oxide Clusters for Magnetic Resonance Imaging

Gd(III) complex conjugated ultra-small iron oxide as an enhanced T1-weighted MR imaging contrast agent

Controlled Synthesis Of Mnfe2o4 Nanoparticles And Gd Complex-Based Nanocomposites As Tunable And Enhanced T-1/T-2-Weighted Mri Contrast Agents

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Biomass-Derived Organonanomaterials As Contrast Agents for Efficient Magnetic Resonance Imaging

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Investigation of magnetic resonance contrast properties of PEG-Coated gadolinium oxide nanoparticles in various biological environments

Controlled Self-Assembling Of Gadolinium Nanoparticles As Smart Molecular Magnetic Resonance Imaging Contrast Agents

Alginate-Derivative Encapsulated Carbon Coated Manganese-Ferrite Nanodots for Multimodal Medical Imaging

Progress in research of nanomedicine-based gadolinium contrast agents for magnetic resonance imaging

Poly(Acrylic Acid) Bridged Gadolinium Metal-Organic Framework-Gold Nanoparticle Composites As Contrast Agents for Computed Tomography and Magnetic Resonance Bimodal Imaging

Gadolinium (III) oxide nanoparticles coated with folic acid-functionalized poly(β-cyclodextrin-co-pentetic acid) as a biocompatible targeted nano-contrast agent for cancer diagnostic: in vitro and in vivo studies

Core/Shell Fe3o4/Gd2o3 Nanocubes As T-1-T-2 Dual Modal Mri Contrast Agents

Gadolinium-doped fluorescent carbon quantum dots as MRI contrast agents and fluorescent probes

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Outstanding MRI contrast with dysprosium phosphate nanoparticles of tuneable size

Synthesis and characterization of PEG-coated Zn$_{0.3}$Mn$_x$Fe$_{2.7-x}$O$_4$ nanoparticles as the dual T1/T2-weighted MRI contrast agent